CRYOPORT, INC. Stock Repurchased During Period, Shares
Shares the company repurchased and the cash it paid, as filed in its 10-Q and 10-K XBRL (statement of shareholders' equity and cash flow statement).
- CRYOPORT, INC. stock repurchased during period, shares for the quarter ending 2024-03-31 was 0.00 shares.
- CRYOPORT, INC. stock repurchased during period, shares for the quarter ending 2023-12-31 was 0.00 shares, a 100.00% decline year-over-year.
- CRYOPORT, INC. stock repurchased during period, shares for the quarter ending 2023-09-30 was 0.00 shares.
- CRYOPORT, INC. stock repurchased during period, shares for the quarter ending 2023-06-30 was 0.00 shares.
- CRYOPORT, INC. stock repurchased during period, shares for fiscal 2023 was 0.00 shares, a 100.00% decline from fiscal 2022.
- CRYOPORT, INC. stock repurchased during period, shares for fiscal 2022 was 1.60M shares.
| Period end | Stock Repurchased During Period, Shares 3 month | Stock Repurchased During Period, Shares 12 month |
|---|---|---|
| 2024-03-31 | 0.00 shares 10-Q · filed 2024-05-08 | 0.00 shares derived: sum of 4 quarters · filed 2024-05-08 |
| 2023-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-13 | 0.00 shares 10-K · filed 2024-03-13 |
| 2023-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | 263.42K shares derived: sum of 4 quarters · filed 2024-05-08 |
| 2023-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09 | 263.42K shares derived: sum of 4 quarters · filed 2024-05-08 |
| 2023-03-31 | 0.00 shares 10-Q · filed 2024-05-08 | -6.70M shares derived: sum of 4 quarters · filed 2024-05-08 |
| 2022-12-31 | 263.42K shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-13 | 1.60M shares 10-K · filed 2024-03-13 |
| 2022-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-04 | |
| 2022-06-30 | -6.96M shares derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04 | |
| 2022-03-31 | 8.30M shares 10-Q · filed 2022-05-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Theravance Biopharma, Inc. (TBPH) | $0.885B | 16.40 | |
| RIGEL PHARMACEUTICALS INC (RIGL) | United States | $0.893B | 2.25 |
| Apnimed, Inc. (APMD) | United States | $0.899B | |
| ARDELYX, INC. (ARDX) | United States | $0.857B | -22.86 |
| Avalo Therapeutics, Inc. (AVTX) | United States | $0.842B | -9.74 |
| Immix Biopharma, Inc. (IMMX) | United States | $0.837B | -18.44 |
| Obsidian Therapeutics, Inc. (OBX) | United States | $0.829B | |
| Jade Biosciences, Inc. (JBIO) | United States | $0.936B | -9.21 |
| LEXICON PHARMACEUTICALS, INC. (LXRX) | United States | $0.823B | -17.48 |
| GYRE THERAPEUTICS, INC. (GYRE) | United States | $0.818B | -24.71 |